Diffusion MRI and novel texture analysis in osteosarcoma xenotransplants predicts response to anti-checkpoint therapy
about
Improving tumour heterogeneity MRI assessment with histograms.Biomarkers in preclinical cancer imaging.The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis.A regimen combining the Wee1 inhibitor AZD1775 with HDAC inhibitors targets human acute myeloid leukemia cells harboring various genetic mutations.Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer.Applications and limitations of radiomicsApparent diffusion coefficient histogram shape analysis for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.Radiomics: a new application from established techniques.Tim-3 as a diagnostic and prognostic biomarker of osteosarcoma.Diagnostic assessment of osteosarcoma chemoresistance based on Virtual Clinical Trials.MRI texture features may predict differentiation and nodal stage of cervical cancer: a pilot study.Preclinical Imaging for the Study of Mouse Models of Thyroid Cancer.Use of texture analysis based on contrast-enhanced MRI to predict treatment response to chemoradiotherapy in nasopharyngeal carcinoma.Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).Histogram Profiling of Postcontrast T1-Weighted MRI Gives Valuable Insights into Tumor Biology and Enables Prediction of Growth Kinetics and Prognosis in Meningiomas.Whole Tumor Histogram-profiling of Diffusion-Weighted Magnetic Resonance Images Reflects Tumorbiological Features of Primary Central Nervous System Lymphoma.
P2860
Q27693208-0A80FAC1-091C-47D0-BC60-906D3DEB5D0FQ30416864-BFCFDB9A-2127-41DE-A904-C8A2A135771EQ33823191-78D46586-F8E2-4EF7-B258-1FB851BD23DEQ35287823-C5C02FD7-B986-488B-9264-64A77DEC1985Q36271681-435EE38E-47F8-433E-9EC3-9A57978C23E4Q37052862-5C4F9511-9A7E-49FA-83FA-5840918844D9Q37359333-23A0DFC9-D631-4960-972A-60C2ECAC7BD2Q39044635-45A80A62-52DE-47B5-8F2B-45361C6DEF68Q40137306-0591346E-5974-4AD3-9747-043A4C86030AQ42843612-78748A09-1DE3-483A-A7A0-5D04C6AB6A98Q48099992-56485A8A-ED0A-4E8B-8093-FFE0F7E9243DQ49475238-AF3DE4B9-3A40-4EBA-A3C7-1D0B1331D457Q50540042-B6AA837A-00AC-49A9-9CF1-D1F7F139055DQ52952263-13C3577B-A09C-4467-ACFE-5751F149E8A5Q55327150-10884E88-EFF9-404B-8635-C90FC99ED807Q55341200-988B37D6-1E21-4943-B230-E7F1AA050A30
P2860
Diffusion MRI and novel texture analysis in osteosarcoma xenotransplants predicts response to anti-checkpoint therapy
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Diffusion MRI and novel textur ...... nse to anti-checkpoint therapy
@ast
Diffusion MRI and novel textur ...... nse to anti-checkpoint therapy
@en
type
label
Diffusion MRI and novel textur ...... nse to anti-checkpoint therapy
@ast
Diffusion MRI and novel textur ...... nse to anti-checkpoint therapy
@en
prefLabel
Diffusion MRI and novel textur ...... nse to anti-checkpoint therapy
@ast
Diffusion MRI and novel textur ...... nse to anti-checkpoint therapy
@en
P2093
P2860
P1433
P1476
Diffusion MRI and novel textur ...... nse to anti-checkpoint therapy
@en
P2093
David L Morse
Gary V Martinez
Jenny M Kreahling
Mark C Lloyd
Meera Raghavan
Olya Grove
Parastou Foroutan
Soner Altiok
P2860
P304
P356
10.1371/JOURNAL.PONE.0082875
P407
P577
2013-12-16T00:00:00Z